Clinical Trial Update: JET-GBS - Japanese Eculizumab Trial for GBS [Phase 2]

View source ↗

Summary

The update notes the completion status of a Phase 2 Japanese trial evaluating eculizumab for Guillain-Barré syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Chiba University | Conditions: Gullain Barre Syndrome | Phase 2 | Status: COMPLETED